Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Cyclophosphamide in treatment of tumefactive multiple sclerosis.

< BACK TO ARCHIVE


2020 Nov 11


Mult Scler Relat Disord


http://www.ncbi.nlm.nih.gov/pubmed/33246262?dopt=Abstract


47

Cyclophosphamide in treatment of tumefactive multiple sclerosis.

Authors

Cyclophosphamide in treatment of tumefactive multiple sclerosis.
Fereidan-Esfahani M, Tobin OW
Mult Scler Relat Disord. 2020 Nov 11; 47:102627.
PMID: 33246262.

Abstract

. To review the Mayo clinic experience of cyclophosphamide in the treatment of tumefactive Multiple Sclerosis (TMS).
Read This Paper